ESR2 and neoplasm: Indeed, it has been recently reported that activation of ERβ in human medulloblastoma cell lines increased cell growth and cell migration [8], and ER antagonist, ICI182,780, inhibited medulloblastoma tumor growth in subcutaneous D283Med nude mouse model [8].